<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Myocardial perfusion in apical ballooning syndrome: Correlate of myocardial injury
2
Myocardial perfusion in children with sickle cell disease
3
Myocardial perfusion in patients with permanent ventricular pacing and normal coronary arteries  
4
Myocardial perfusion in real-time using power modulation: In vivo evidence for microcirculatory damage after acute myocardial infarction
5
Myocardial perfusion magnetic resonance imaging for detecting coronary function anomalies in asymptomatic paediatric patients with a previous arterial switch operation for the transposition of great arteries
6
Myocardial Perfusion Magnetic Resonance Imaging Using Sliding-Window Conjugate-Gradient Highly Constrained Back-Projection Reconstruction for Detection of Coronary Artery Disease
7
Myocardial perfusion pattern in patients with cocaine-induced chest pain
8
Myocardial perfusion reserve and peripheral endothelial function in patients with idiopathic dilated cardiomyopathy
9
myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging
10
Myocardial Perfusion Scintigraphy (Gated-SPECT) and Coronary Disease Risk Factors in Behçet’s Disease with Metabolic Syndrome
11
Myocardial Perfusion Scintigraphy and Value in Patients With Non-ST Segment Elevation Acute Coronary Syndromes
12
Myocardial perfusion single photon computed tomography: An Atlas
13
Myocardial perfusion SPECT and dobutamine stress tissue Doppler imaging in evaluation of patients with stable angina pectoris
14
Myocardial Perfusion SPECT Imaging in Dextrocardia with Situs Inversus: A Case Report
15
Myocardial perfusion SPECT: Perfusion quantification
16
Myocardial Perfusion Study of Panic Attacks in Patients With Coronary Artery Disease
17
Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers Original Research Article
18
Myocardial Preconditioning Produced by Ischemia, Hypoxia, and a KATPChannel Opener: Effects on Interstitial Adenosine in Dogs
19
Myocardial preservation during coronary surgery with and without cardiopulmonary bypass
20
Myocardial preservation using celsior solution in cardiac transplantation: early results and 5-year follow-up of a multicenter prospective study of 70 cardiac transplantations
21
Myocardial protection
22
Myocardial protection and esmolol in blood perfused rat hearts  
23
Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor
24
Myocardial protection during antegrade versus retrograde cardioplegia
25
Myocardial Protection During Elective Coronary Artery Bypass Grafting Using High-Dose Insulin Therapy
26
Myocardial protection during reperfusion by administration of caspase-3 inhibitor is mediated via PI3 kinase survival pathway  
27
Myocardial protection evoked by hyperoxic exposure involves signaling through nitric oxide and mitogen activated protein kinases  
28
Myocardial protection for acquired heart disease surgery: Results of a national survey
29
Myocardial protection for coronary bypass grafting: The Toronto Hospital perspective
30
Myocardial protection for neonatal cardiac surgery-the developmental status and ischemic damage in human heart cell
31
Myocardial protection in the immature heart
32
Myocardial Protection of Contractile Function After Global Ischemia by Physiologic Estrogen Replacement in the Ovariectomized Rat
33
Myocardial protection of the failing heart
34
Myocardial protection using diadenosine tetraphosphate with pharmacological preconditioning
35
Myocardial protection with endogenous overexpression of manganese superoxide dismutase
36
Myocardial protection with intermittent cold blood during aortic valve operation: antegrade versus retrograde delivery
37
Myocardial protection with intermittent cross-clamp fibrillation: Improvement with sodium-hydrogen exchange inhibition
38
Myocardial protection with pinacidil cardioplegia in the blood-perfused heart
39
Myocardial protection with postconditioning is not enhanced by ischemic preconditioning
40
Myocardial protection with potassium-channel openers is as effective as St. Thomasʹ solution in the rabbit heart
41
Myocardial protection with Sevoflurane in Coronary Artery Bypass Grafting Surgery
42
Myocardial Protection with Simultaneous Antegrade/Vein Graft Cardioplegia Compared to Antegrade Cardioplegia Alone in Elective Coronary Artery Bypass Grafting Patients
43
MYOCARDIAL PROTECTION: A CLINICAL COMPARISON OF COLD BLOOD CARDIOPLEGIA AND COLD CRYSTALLOID CARDIOPLEGIA
44
Myocardial protection: Efficacy of RS-C (Aqix®), a novel magnesium-cardioplegia, compared to St Thomasʹ hospital solution
45
Myocardial protection: Modern studies
46
MYOCARDIAL PROTECTION: NEW STRATEGIES FOR PREVENTING LETHAL REFERFUSION INJURY
47
Myocardial protective efficacy of lidocaine (with or without adenosine) as agents to induce polarised cardioplegic arrest during global ischaemia in rat hearts
48
Myocardial recovery after mechanical support for acute myocarditis: is sustained recovery predictable?
49
Myocardial Recovery and the Failing Heart: Myth, Magic, or Molecular Target?
50
Myocardial Redox State Predicts In-Hospital Clinical Outcome After Cardiac Surgery: Effects of Short-Term Pre-Operative Statin Treatment
51
Myocardial regeneration by endogenous adult progenitor cells
52
Myocardial regeneration by human amniotic fluid stem cells: Challenges to be overcome
53
Myocardial Regeneration by Stem Cells: Seeing the Unseeable
54
Myocardial regeneration with bone-marrow-derived stem cells
55
Myocardial regeneration: Roles of stem cells and hydrogels
56
Myocardial Regenerative Therapy: Immunologic Basis for the Potential “Universal Donor Cells”
57
Myocardial remodeling differs between LV and RV myocardium from patients with idiopathic-dilated myocarditis, end-stage heart failure  
58
Myocardial Remodeling Is Controlled by Myocyte-Targeted Gene Regulation of Phosphodiesterase Type 5
59
Myocardial remodelling in a mouse model of diabetic cardiomyopathy
60
Myocardial response to ischemic preconditioning: is it a novel predictor of prognosis?
61
Myocardial revascularisation after acute myocardial infarction
62
Myocardial revascularisation by laser
63
Myocardial revascularisation: the search for the Holy Grail
64
Myocardial revascularization
65
Myocardial revascularization for acute myocardial infarction: benefits and drawbacks of avoiding cardiopulmonary bypass
66
Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: Functional Observations
67
Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery
68
Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of strategy on midterm outcome
69
Myocardial revascularization with and without cardiopulmonary bypass in multivessel disease: impact of the strategy on early outcome
70
Myocardial revascularization with multiple arterial grafts: comparison between the radial artery and the right internal thoracic artery
71
Myocardial revascularization with radial and mammary arteries: initial and mid-term results
72
Myocardial revascularization with the left internal thoracic artery graft configuration
73
Myocardial revascularization with the posterior tibial artery
74
Myocardial revascularization with the radial artery: a clinical and angiographic study
75
Myocardial rupture after myocardial infarction is related to the perfusion status of the infarct-related coronary artery
76
Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: a randomised trial
77
Myocardial salvage by the use of reperfusion and intraaortic balloon pump: Experimental study
78
Myocardial salvage in patients with non–ST-elevation myocardial infarction determined by myocardial perfusion imaging
79
Myocardial Salvage Index and Infarct Size Represent Related But Distinct Components of Acute ST-Segment Elevation Myocardial Infarction
80
Myocardial Scar Detected by Cardiovascular Magnetic Resonance in a Competitive Bodybuilder With Longstanding Abuse of Anabolic Steroids
81
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
82
Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy
83
Myocardial Scars More Frequent Than Expected: Magnetic Resonance Imaging Detects Potential Risk Group Original Research Article
84
Myocardial scintigraphic study with 123I 15-(p-iodophenyl)-3(R,S)-methylpentadecanoic acid in patients with hypertrophic cardiomyopathy
85
Myocardial scintigraphy in a patient with transient mid-ventricular ballooning cardiomyopathy: Case report
86
Myocardial scintigraphy in acute myocardial infarction treated with systemic thrombolysis: how far are we from obtaining reliable information for rescue PTCA?
87
Myocardial self-preservative effect of heat shock protein 70 on an immature lamb heart
88
Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus Original Research Article
89
Myocardial Strain and Strain Rate Imaging: Comparison between Doppler Derived Strain Imaging and Speckle Tracking Echocardiography
90
Myocardial Strain and Torsion Quantified by Cardiovascular Magnetic Resonance Tissue Tagging: Studies in Normal and Impaired Left Ventricular Function Review Article
91
Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy
92
Myocardial strain rate is a superior method for evaluation of left ventricular subendocardial function compared with tissue Doppler imaging
93
Myocardial strain: can we finally measure contractility?
94
Myocardial Structural Effects of Aldosterone Receptor Antagonism in Heart Failure
95
Myocardial stunning after cerebral infarction
96
Myocardial stunning after off-pump coronary artery bypass grafting: safeguards and pitfalls
97
Myocardial stunning after off-pump coronary artery bypass grafting: safeguards and pitfalls: Reply
98
Myocardial stunning associated with a myocardial bridge
99
Myocardial stunning in hypertrophic cardiomyopathy with normal coronary arteries
100
Myocardial Substrate Oxidation During Warm Continuous Blood Cardioplegia
101
Myocardial sympathetic denervation prevents chamber-specific alteration of beta-adrenergic transmembrane signaling in rabbits with heart failure
102
Myocardial sympathetic innervation in patients with impaired glucose tolerance: relationship to subclinical inflammation
103
Myocardial Systolic Strain is Decreased After Aortic Valve Replacement in Patients With Aortic Insufficiency
104
Myocardial tactile stiffness during acute reduction of coronary blood flow
105
Myocardial Tactile Stiffness: Variable of Regional Myocardial Function
106
Myocardial Technetium-99m-Tetrofosmin Single-Photon Emission Computed Tomography Compared With 18F-Fluorodeoxyglucose Imaging to Assess Myocardial Viability
107
Myocardial Thievery: The Coronary-Subclavian Steal Syndrome
108
Myocardial time intervals preceding left ventricular filling in chronic coronary artery disease: value of a decreased septal ejection time
109
Myocardial tissue Doppler and long axis function in the fetal heart
110
Myocardial Tissue Doppler-Based Indexes to Distinguish Right Ventricular Volume Overload from Right Ventricular Pressure Overload
111
Myocardial tissue troponins T and I: An immunohistochemical study in experimental models of myocardial ischemia
112
Myocardial tissue velocity reduction is correlated with clinical neurologic severity in myotonic dystrophy
113
Myocardial toxoplasmosis complicating cardiac transplant
114
Myocardial transversely isotropic material parameter estimation from in-silico measurements based on a reduced-order unscented Kalman filter
115
Myocardial tumor necrosis factor–α expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support
116
Myocardial vacuolization, a marker of ischemic injury, in surveillance cardiac biopsies posttransplant: Correlations with morphologic vascular disease and endothelial dysfunction
117
MYOCARDIAL VASCULAR DYSFUNCTION FOLLOWING HEART SURGERY: IS ENOS ACTIVATION INVOLVED?
118
Myocardial velocity gradient as new indicator of regional left ventricular contraction: Detection by two-dimensional tissue doppler imaging technique
119
Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy
120
Myocardial ventricular mass related to coronary artery distribution in human hearts
121
Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction
122
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial
123
Myocardial viability assessed by Dobutamine echocardiography in acute myocardial infarction after successful primary coronary angioplasty
124
Myocardial viability assessed by positron emission tomography in infants and children after the arterial switch operation and suspected infarction  
125
Myocardial Viability Assessment by Cardiac MRI in Cases of Pediatric Cardiomyopathy
126
Myocardial viability assessment by contrast-enhanced magnetic resonance imaging
127
Myocardial viability assessment by endocardial electroanatomic mapping: comparison with metabolic imaging and functional recovery after coronary revascularization
128
Myocardial Viability Assessment: Comparison between Resting Two Dimensional Visual Assessment of Dobutamine Stress Echocardiography and Strain Rate Imaging
129
Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction
130
Myocardial Viability Imaging: Dead or Alive?
131
Myocardial viability in patients with chronic coronary artery disease and previous myocardial infarction: Comparison of myocardial contrast echocardiography and myocardial perfusion scintigraphy
132
Myocardial viability inchronic ischemic heart disease: Comparison of contrast-enhanced magnetic resonance imaging with 18F-fluorodeoxyglucose positron emission tomography
133
Myocardial Viability Mapping by Magnetic Resonance-Based Multiparametric Systolic Strain Analysis
134
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure
135
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
136
Myocardial viability: Contractile reserve or cell membrane integrity?
137
Myocardial viability: Methods of assessment and clinical relevance
138
Myocardial Wall Thickness and Left Ventricular Geometry in Hypertensives: Relationship With Insulin
139
Myocardial wall thickness predicts recovery of contractile function after primary coronary intervention for acute myocardial infarction Original Research Article
140
Myocardial wall velocity assessment by pulsed Doppler tissue imaging: Characteristic findings in normal subjects
141
Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic Mice
142
Myocardial-Infraction Based on Intelligent Techniques
143
Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block
144
Myocardialβ-adrenergic and Muscarinic Receptor Density in Cardiac Pressure or Volume Overload
145
Myocardin and smooth muscle differentiation
146
Myocardin: A Component of a Molecular Switch for Smooth Muscle Differentiation
147
Myocardiocyte apoptosis in heart failure in chronic Chagasʹ disease
148
Myocarditis and cardiomyopathy associated with clozapine
149
Myocarditis and idiopathic dilated cardiomyopathy
150
Myocarditis and long-term survival in peripartum cardiomyopathy
151
Myocarditis and Meningitis during Early Sepsis in a Neonate with Streptococcus pseudopneumoniae: A Case Report
152
Myocarditis and primary Sjögrenʹs syndrome
153
Myocarditis and primary Sjogrenʹs syndrome Original Research Article
154
Myocarditis and subcutaneous granulomas in a patient with Crohnʹs disease of the colon
155
Myocarditis associated with 2009 influenza A (H1N1) virus in children
156
Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management
157
Myocarditis Complicating Pregnancy in Dengue Hemorrhagic Fever- A Case Report
158
Myocarditis Diagnosed in Twins
159
Myocarditis due to Salmonella virchow and sudden infant death
160
Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms
161
Myocarditis in systemic lupus erythematosus
162
Myocarditis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy
163
Myocarditis with ST-Elevation Myocardial Infarction presentation in young man. A case series of 11 patients
164
Myocarditis, a Life-Threatening Presentation of COVID-19 in a 4-Month-Old Infant
165
Myocarditis, Pericarditis, and Cardiac Tamponade Associated With Rocky Mountain Spotted Fever
166
Myocarditis: the unexpected return of smallpox vaccine adverse events
167
Myocardium proteome remodelling after nutritional deprivation of methyl donors
168
Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response
169
Myocilin Mutations Are Not a Major Cause of Primary Congenital Glaucoma in Iranian Patients
170
Myoclonic encephalopathy after exposure to aluminium
171
Myoclonic encephalopathy in the CDKL5 gene mutation
172
Myoclonic epilepsy masquerading as a tic disorder
173
Myoclonic seizures combined with partial seizures and probable pathophysiology of secondary bilateral synchrony
174
Myoclonic status epilepticus following high-dosage lamotrigine therapy
175
Myoclonic–astatic epilepsy of early childhood – clinical and EEG analysis of myoclonic–astatic seizures, and discussions on the nosology of the syndrome
176
Myoclonus associated with etomidate for ED procedural sedation and analgesia
177
Myoclonus, Seizure, and Ventricular Fibrillation after Intrathecal Injection of Tranexamic Acid
178
Myoclonus: current concepts and recent advances
179
Myocutaneous Mucormycosis in a Diabetic Burnt Patient Led to Upper Extremity Amputation; A Case Report
180
Myocyte Apoptosis and Reduced SR Gene Expression Precede the Transition from Chronically Stunned to Hibernating Myocardium
181
Myocyte apoptosis: programming ventricular remodeling
182
Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest
183
Myocyte damage in myopathic cell model
184
Myocyte degeneration and cell death in hibernating human myocardium
185
Myocyte diameter and fractional area of collagen are not associated with survival time of outpatients with idiopathic dilated cardiomyopathy: A study based on right ventricular endomyocardial biopsies
186
Myocyte electrophysiological properties following the development of supraventricular tachycardia-induced cardiomyopathy
187
Myocyte Growth and Cardiac Repair
188
Myocyte nuclear area as a measure of left ventricular hypertrophy in transplant patients
189
Myocyte production of nitric oxide in response to AChR-reactive antibodies in two inbred rat strains may influence disease outcome in experimental myasthenia gravis
190
Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart
191
Myocytes die by multiple mechanisms
192
Myocytes Isolated from Rejecting Transplanted Rat Hearts Exhibit a Nitric Oxide-mediated Reduction in the Calcium Current
193
Myocytes Isolated From Rejecting Transplanted Rat Hearts Exhibit Reduced Basal Shortening Which is Reversible by Aminoguanidine
194
Myocytes Respond to both Interleukin-4 and Interferon-γ: Cytokine Responsiveness with the Potential to Influence the Severity and Course of Experimental Myasthenia Gravis
195
Myoelectric Activity of Individual Lumbar Erector Spinae Muscles Variation by Differing Seat Pan Depth
196
Myoelectric manifestations of sternocleidomastoid and anterior scalene muscle fatigue in chronic neck pain patients
197
MYOELECTRIC RESPONSE OF BACK MUSCLES TO VERTICAL RANDOM WHOLE-BODY VIBRATION WITH DIFFERENT MAGNITUDES AT DIFFERENT POSTURES
198
Myoelectric signal compression using zero-trees of wavelet coefficients
199
Myoendometrial versus placental uterine arteries: Structural, mechanical, and functional differences in late-pregnant rabbits
200
Myoepithelial cell cocktail (p63+SMA) for the evaluation of sclerosing breast lesions
201
Myoepithelioma metatatic to the orbit
202
Myoepithelioma of the breast
203
Myofascial Pain and Dysfunction: The Trigger Point Manual, Vol 1: Upper Half of Body (2nd Ed.): Authors: Simons, Travell and Simons; Publisher: Williams and Wilkins, 1999; Pages: 1038 pp
204
Myofascial Pain Dysfunction Syndrome (MPDS)
205
Myofascial pain syndromes and their evaluation
206
Myofiber angle distributions in the ovine left ventricle do not conform to computationally optimized predictions
207
Myofiberbreak-up: A marker of ventricular fibrillation in sudden cardiac death
208
Myofibrillar 1-D fingerprints and myosin heavy chain MS analyses of beef loin at 36 h postmortem correlate with tenderness at 7 days
209
Myofibrillar protein extracts from spent hen meat to improve whole muscle processed meats
210
Myofibrillar protein oxidation induced by post-ischemic reperfusion in isolated rat hearts
211
Myofibrillar protein profile of Pectoralis major muscle in broiler chickens subjected to different freezing and thawing methods
212
Myofibrillar troponin C Ca binding kinetics in heart cells at rest are like soluble troponin C kinetics
213
Myofibrillar Troponin Exists in Three States and there Is Signal Transduction along Skeletal Myofibrillar Thin Filaments
214
Myofibroblastic Sarcoma in the Limb of a Horse
215
Myofibroblastoma and solitary fibrous tumour of the breast: histopathologic and immunohistochemical studies
216
Myofibroblastoma of the Breast: A Morphologic and Immunohistochemical Study of Three Cases
217
Myofibroblastoma of the Breast: Literature Review andCase Report
218
Myofibroblasts and hepatocellular carcinoma: an in vivo and in vitro study
219
Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study
220
Myofibroblasts in Calcifying Odontogenic Cyst and Dentigerous Cyst
221
Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization
222
Myofibroblasts overexpress osteonectin in hepatocellular carcinoma (HCC)
223
Myofibroma as a Rapidly Growing Gingival Mass in a 4-year-old Boy: a Case Report
224
Myofilament and cytoskeleton proteins: Fine machineries of biological movements
225
Myofilament incorporation and contractile function after gene transfer of cardiac troponin I Ser43/45Ala
226
Myofilament incorporation determines the stoichiometry of troponin I in transgenic expression and the rescue of a null mutation
227
Myogenesis in sheep is altered by maternal feed intake during the peri-conception period
228
Myogenic and flow-mediated responses in isolated mesenteric small arteries from pregnant and nonpregnant rats
229
Myogenic Differentiation Potential of Human Newborn Foreskin Stem Cells Combined with Polycaprolactone-Based Nanofiber
230
Myogenic Endothelial Cells Purified From Human Skeletal Muscle Improve Cardiac Function After Transplantation Into Infarcted Myocardium Original Research Article
231
Myogenic nature of insect heartbeat and intestinal peristalsis, revealed by neuromuscular paralysis caused by the sting of a braconid wasp
232
Myogenic reactivity is enhanced in rat radial uterine arteries in a model of maternal undernutrition
233
Myogenic signaling by lithium in cardiomyoblasts is Akt independent but requires activation of the β-catenin-Tcf/Lef pathway
234
Myogenin and Class II HDACs Control Neurogenic Muscle Atrophy by Inducing E3 Ubiquitin Ligases
235
Myogenous Temporomandibular Disorders: Diagnostic and Management Considerations
236
Myoglobin (MYO) and cardiac troponin I (CTNI) in diagnosis of suspected acute myocardial infarct (AMI)-Myoglobin (MYO) and cardiac troponin I (CTNI) in diagnosis of suspected acute myocardial infarct (AMI)
237
Myoglobin adsorption onto poly(glycidyl methacrylate) microbeads with surface functionalized iminodiacetic acid
238
Myoglobin and haemoglobin-mediated lipid oxidation in washed muscle: Observations on crosslinking, ferryl formation, porphyrin degradation, and haemin loss rate
239
Myoglobin and lipid oxidation interactions: Mechanistic bases and control
240
Myoglobin as a model system for designing heme protein based blood substitutes Original Research Article
241
Myoglobin as marker in meat adulteration: A UPLC method for determining the presence of pork meat in raw beef burger
242
Myoglobin dynamics: evidence for a hybrid solid/fluid state of matter
243
Myoglobin Expression in Chelonia mydas Brain, Heart and Liver Tissues
244
Myoglobin immobilization on electrodeposited nanometer-scale nickel oxide particles and direct voltammetry Original Research Article
245
Myoglobin immobilized on LaF3 doped CeO2 and ionic liquid composite film for nitrite biosensor
246
Myoglobin in polyacrylamide hydrogel films: direct electrochemistry and electrochemical catalysis
247
Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: A Thrombolysis in Myocardial Infarction 10B substudy
248
Myoglobin modified electrodes as anchors for d metal cationic complexes
249
Myoglobin within graphene oxide sheets and Nafion composite films as highly sensitive biosensor
250
Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain
251
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: Results from TIMI 10A, , , ,
252
Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction : Results from the thrombolysis in myocardial infarction study (TIMI) 10B
253
Myoglobin/arylhydroxylamine film modified electrode: Direct electrochemistry and electrochemical catalysis
254
Myoglobin-Catalyzed bis-Allylic Hydroxylation and Epoxidation of Linoleic Acid
255
Myoglobin-Induced Oxidative Damage: Evidence for Radical Transfer from Oxidized Myoglobin to Other Proteins and Antioxidants
256
Myoid Angioendothelioma of the Spleen: A Rare Case Report and Literature Review
257
Myoid hamartoma of breast with chondroid metaplasia: a casereport
258
Myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3,4-trisphosphorothioate: New synthetic Ca2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor
259
myo-Inositol 4,6-carbonate: an easily prepared small molecule with three syn-axial hydroxyl groups
260
Myo-inositol at High Concentration Reduced Viability and Proliferation of Rat Bone Marrow Mesenchymal Stem Cells via Electrolyte Imbalance and Elevation of Aerobic Metabolism
261
Myo-inositol catabolism by Rhizobium in soil: HPLC and enzymatic studies
262
Myo-inositol catabolism by Rhizobium in soil: HPLC and enzymatic studies
263
Myo-inositol effect on pregnancy outcomes in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: A double-blind RCT
264
myo-Inositol esters of indomethacin as COX-2 inhibitors Original Research Article
265
Myo-inositol hexakisphosphate degradation by Bifidobacterium infantis ATCC 15697
266
Myo-inositol in depressive and healthy subjects determined by frontal 1H-magnetic resonance spectroscopy at 1.5 tesla
267
myo-Inositol Monophosphatase from Rat Testes: Purification and Properties
268
Myo-Inositol Monophosphatase: Binding of Terbium and a Cross-Linking Reagent to the Catalytic Site Cavity
269
myo-Inositol Oxygenase Offers a Possible Entry Point into Plant Ascorbate Biosynthesis
270
Myoiti aociated with a Baerveldt glaucoma implant
271
Myokymia and neuromyotonia in 37 Jack Russell terriers
272
Myokymia and neuromyotonia in veterinary medicine: A comparison with peripheral nerve hyperexcitability syndrome in humans
273
Myoma expulsion after uterine artery embolization: Complication or cure?
274
Myomectomy fever: testing the dogma
275
Myomesin 3, a Novel Structural Component of the M-band in Striated Muscle
276
Myomesin is a Molecular Spring with Adaptable Elasticity
277
Myometrial Apoptosis: Activation of the Caspase Cascade in the Pregnant Rat Myometrium at Midgestation
278
Myometrial arginase activity increases with advancing pregnancy in the guinea pig, , ,
279
Myometrial contractile strain at uteroplacental separation during parturition
280
Myometrial function in prematurity
281
Myometrial hyperplasia in pediatric, adolescent, and young adult uteri
282
Myometrial LH/hCG receptors during the estrous cycle and pregnancy in pigs
283
Myometrial nitric oxide synthase messenger ribonucleic acid expression does not change throughout gestation or with the onset of labor,
284
Myometrial thickness during human labor and immediately post partum
285
Myonecrosis After Revascularization Procedures
286
Myopathic involvement in two cases of Hallervorden-Spatz disease
287
Myopathy in acquired partial lipodystrophy
288
Myopathy resulted from the excessive long administration of Traimecinolone
289
Myopathy, Statins, and Vitamin D Deficiency
290
Myopathy-dependent changes in activity of ATPase, SDH and GPDH and NOS expression in the different fibre types of hamster muscles
291
Myopericarditis: Etiology, management, and prognosis
292
Myopia and Inflammation
293
Myopia and its mechanisms
294
Myopia and Regional Variations in Retinal Thickness in Healthy Eyes
295
Myopia and viion 2020
296
Myopia Control: A Citation Network Study
297
Myopia in Adult with Retinopathy of Prematurity Original Reearch Article
298
Myopia Progression in Low Birth Weight Infants: A Narrative Review
299
Myopia, liquidity constraints, and aggregate consumption: what do the data say?
300
Myopia, redistribution and pensions
301
Myopic and perfect foresight in the OLG model
302
Myopic atigmatim and prebyopia
303
Myopic atigmatim and prebyopia trial
304
Myopic atigmatim: abtract v article
305
Myopic biases in competitions
306
Myopic loss aversion, disappointment aversion, and the equity premium puzzle
307
Myopic loss aversion: Information feedback vs. investment flexibility
308
Myopic prediction, self-destructive secrecy, and the unexpected benefits of revealing final deadlines in negotiation
309
Myopic prospect theory vs. myopic loss aversion: how general is the phenomenon?
310
Myopic random walkers and exclusion processes: Single and multispecies
311
Myopic Regreion After Laer In itu Keratomileui: A Medical Alternative to urgical Enhancement
312
Myopic Social Prediction and the Solo Comparison Effect
313
Myopic trabimu fixu: a mitochondrial myopathy?
314
Myoplasmic Ca2+ concentration during exertional rhabdomyolysis
315
MyoRing Implantation in Keratoconic Patients: 3 years Follow-up Data
316
MyoRing Implantation with and without Corneal Collagen Crosslinking for the Management of Keratoconus
317
Myosin and kinesin: mother and child reunited
318
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy Original Research Article
319
Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle
320
Myosin Binding Protein C Positioned to Play a Key Role in Regulation of Muscle Contraction: Structure and Interactions of Domain C1
321
Myosin binding protein-C: structural and functional complexity
322
Myosin Binding Surface on Actin Probed by Hydroxyl Radical Footprinting and Site-Directed Labels
323
Myosin cross-bridge mechanics: geometrical determinants for continuous sliding
324
Myosin dynamics on the millisecond time scale Original Research Article
325
Myosin expression in the jaw-closing muscles of the domestic cat and american opossum
326
Myosin filament depolymerizes in a low ionic strength solution containing l-histidine
327
Myosin from failing and non-failing human ventricles exhibit similar contractile properties
328
Myosin head mechanical performance under different conformational change mechanisms
329
Myosin Heads in Solution: How to Interpret the Data Obtained by Means of X-Ray and Neutron Scattering?
330
Myosin heavy chain and fibre diameter of extrinsic tongue muscles in rhesus monkey
331
Myosin heavy chain B isoform is more predominant in rat veins than arteries
332
Myosin heavy chain degradation during post mortem storage of Atlantic cod (Gadus morhua L.)
333
Myosin heavy chain fibre types and fibre sizes in nuliparous and primiparous ovariectomized Iberian sows: Interaction with two alternative rearing systems during the fattening period
334
Myosin heavy chain isoform composition influences the susceptibility of actin-activated S1 ATPase and myofibrillar ATPase to pH inactivation
335
Myosin heavy chain isoform immunolabelling in diabetic rats with peripheral neuropathy
336
Myosin heavy chain isoforms account for variation in pork quality
337
Myosin heavy chain isoforms expressed in bovine skeletal muscles
338
Myosin heavy chain isoforms influence myofibrillar ATPase activity under simulated postmortem pH, calcium, and temperature conditions
339
Myosin heavy chain profiles and body composition are different in old versus young Standardbred mares
340
Myosin II is important for maintaining regulated secretion and asymmetric localization of chitinase 1 in the budding yeast Saccharomyces cerevisiae
341
Myosin II-Dependent Cortical Movement Is Required for Centrosome Separation and Positioning during Mitotic Spindle Assembly
342
Myosin is solubilized in a neutral and low ionic strength solution containing l-histidine
343
Myosin Isoform Determines the Conformational Dynamics and Cooperativity of Actin Filaments in the Strongly Bound Actomyosin Complex
344
Myosin Learns to Recruit AMPA Receptors
345
Myosin light chain 1 release from myofibrillar fraction during postmortem aging is a potential indicator of proteolysis and tenderness of beef
346
Myosin Light Chain Gene Expression Associated with Disease States of the Human Heart
347
Myosin light chain I grade: A simple marker for the severity and prognosis of patients with acute myocardial infarction, , ,
348
Myosin light chain kinase and pulmonary responses after acute ethanol exposure and burn injury
349
Myosin light chain kinase and the role of myosin light chain phosphorylation in skeletal muscle
350
Myosin light chain kinases and phosphatase in mitosis and cytokinesis
351
Myosin Light Chain Phosphorylation in Cardiac Hypertrophy and Failure due to Myocardial Infarction
352
Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2
353
Myosin Mechanochemistry
354
Myosin phosphatase isoform switching in vascular smooth muscle development
355
Myosin Vb Mobilizes Recycling Endosomes and AMPA Receptors for Postsynaptic Plasticity
356
Myosin VI Rewrites the Rules for Myosin Motors
357
Myosin VI Undergoes Cargo-Mediated Dimerization
358
Myosins and DYNLL1/LC8 in the honey bee (Apis mellifera L.) brain
359
Myosins Are Motor Proteins of the Actomyosin Motility System: Association with Membranes and with the Signal Pathways
360
Myositis Ossificans Circumscripta of the Supra-orbital Region: A Case Report
361
MYOSITIS OSSIFICANS OF HAND
362
Myositis ossificans of the chest wall simulating malignant neoplasm
363
Myositis ossificans of the medial pterygoid muscles: A case report
364
Myositis Ossificans Progressiva in the Whole Spine: A Case Report
365
Myositis ossificans traumatica of the temporal muscle: a case report
366
Myosplint decreases wall stress without depressing function in the failing heart: a finite element model study
367
Myospryn associates to desmin and is important in heart development
368
Myostatin Dominant Negative Allele Products Interact Positively with Wild Type Monomers
369
Myostatin expression is not altered by insulin deficiency and replacement in streptozotocin-diabetic rat skeletal muscles
370
Myostatin gene knockdown through lentiviral-mediated delivery of shRNA for in vitro production of transgenic bovine embryos
371
Myostatin Gene Polymorphism and Its Association with Production Traits in Western Azerbaijan Native Chickens
372
Myostatin gene targeting in cultured China Han ovine myoblast cells
373
Myosteatosis and myofibrosis: Relationship with aging, inflammation and insulin resistance
374
Myostimulatory neuropeptides in cockroaches: structures, distribution, pharmacological activities, and mimetic analogs
375
Myotendinous lengthening of the elbow flexor muscles to improve active motion in patients with elbow spasticity following brain injury
376
Myotilinopathy – A report on four UK patients
377
Myotomy through heart-port access for myocardial bridging
378
Myotonic disorders: A review article
379
Myotonic Dystrophy Confirmed after Cesarean Section
380
Myotonic dystrophy gene identified
381
Myotonic dystrophy is a significant cause of idiopathic polyhydramnios, ,
382
Myotonic Dystrophy Protein Kinase (DMPK) Gene Expression in Lymphocytes of Patients with Myotonic Dystrophy
383
Myotopography in Tibial Lengthening
384
Myotoxic Effects of Atorvastatin Drug (Lipitor) on the Skeletal Muscles of Adult Male Albino Rats and the Effect of L- Carnitine Co-administration Light Microscopical, Immunohistochemical and Biochemical Study
385
Myotoxicity of bupivacaine versus levobupivacaine: histological study in adult albino rats
386
Myotrophin in human heart failure
387
Myotropic effect of helicokinins, tachykinin-related peptides and Manduca sexta allatotropin on the gut of Heliothis virescens (Lepidoptera: Noctuidae)
388
Myrcene Consumption and Restrain Stress: An In Vivo Comparative Study on an Alzheimer’s Disease Model and In Vitro Investigation on Abeta Fibrils
389
Myrciaine, a new nicotinic ester from Myrcia blanchetiana (Myrtaceae)
390
Myriad loses rights to breast cancer gene patent
391
Myriad molecules drive nervous-system development
392
Myriad-Type Polynomial Filtering
393
Myriastramides A–C, new modified cyclic peptides from the Philippines marine sponge Myriastra clavosa
394
MyRice: Pangkalan Data Pengetahuan Padi Malaysia
395
Myricetin affords protection against peroxynitrite-mediated DNA damage and hydroxyl radical formation
396
Myricetin can mitigate altered redox status in type 2 diabetic erythrocytes
397
Myricetin directly targets JAK1 to inhibit cell transformation
398
Myricetin induces pancreatic cancer cell death via the induction of apoptosis and inhibition of the phosphatidylinositol 3-kinase (PI3K) signaling pathway
399
Myricetin inhibits Escherichia coli DnaB helicase but not primase Original Research Article
400
Myricetin sensitizes malignant glioma cells to TRAIL-mediated apoptosis by down-regulation of the short isoform of FLIP and bcl-2
401
Myricetin stimulates the absorption of the pro-carcinogen PhIP
402
Myricetin suppresses LPS-induced MMP expression in human gingival fibroblasts and inhibits osteoclastogenesis by downregulating NFATc1 in RANKL-induced RAW 264.7 cells
403
Myricitrin as a substrate and inhibitor of myeloperoxidase: Implications for the pharmacological effects of flavonoids
404
Myricitrin protects against peroxynitrite-mediated DNA damage and cytotoxicity in astrocytes
405
MYRINGOPLASTY IN SIMPLE CHRONIC OTITIS MEDIA
406
MYRINGOPLASTY, ONLAY VERSUS UNDERLAY TECHNIQUE
407
Myringoplasty: A Comparative Study of Different Graft Materials and Various Surgical Techniques
408
Myringoplasty: A Comparison of Bismuth Iodoform Paraffin Paste Gauze Pack and Plane Gauze (containing Lococotien with Veoform)
409
Myringotomy with versus without grommet tube insertion in chronic serous otitis media with effusion : Southern Oman experience
410
Myriocin prevents fumonisin B1-induced sphingoid base accumulation in mice liver without ameliorating hepatotoxicity
411
Myriocin, an inhibitor of serine palmitoyl transferase, impairs the uptake of transferrin and low-density lipoprotein in mammalian cells
412
Myrionecta rubra (Mesodinium rubrum) bloom initiation in the Columbia River estuary
413
Myrioneurinol: a novel alkaloid skeleton from Myrioneuron nutans
414
Myriophyllum alterniflorum DC. Effect of low concentrations of copper and cadmium on somatic and photosynthetic endpoints: A chemometric approach
415
Myriophyllum alterniflorum DC., biomonitor of metal pollution and water quality. Sorption/accumulation capacities and photosynthetic pigments composition changes after copper and cadmium exposure
416
Myriophyllum aquaticum as a biomonitor of water heavy metal input related to agricultural activities in the Xanaes River (Cَrdoba, Argentina)
417
Myriophyllum spicatum-released allelopathic polyphenols inhibiting growth of blue-green algae Microcystis aeruginosa
418
MYRISTATE BINDING TO ENDOTHELIAL LOCALIZED CD36 MEDIATES THE ACTIVATION OF NITRIC OXIDE SYNTHASE
419
Myristic acid, unlike palmitic acid, is rapidly metabolized in cultured rat hepatocytes
420
Myristic acid/polyaniline composites as form stable phase change materials for thermal energy storage
421
Myristica Fragrans Houtt Extract Attenuates Neuronal Loss and Glial Activation in Pentylenetetrazol-Induced Kindling Model
422
Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils
423
Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to β2-integrin dependent responses of equine neutrophils
424
Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo
425
Myristoylation Cannot Functionally Replace the Isoprenylation of Rab5
426
Myristoylation of Protein at a Distinct Position Allows Its Phosphorylation by Protein Kinase C
427
Myristoylation-regulated Direct Interaction Between Calcium-bound Calmodulin and N-terminal Region of pp60v-src
428
Myrmecochory and short-term seed fate in Rhamnus alaternus: Ant species and seed characteristics
429
Myrmecochory by small ants – Beneficial effects through elaiosome nutrition and seed dispersal
430
Myron Prinzmetal 1908–1987: The man behind the variant angina
431
Myrosinase-generated isothiocyanate from glucosinolates: Isolation, characterization and in vitro antiproliferative studies Original Research Article
432
Myrrh a traditional medicine or a multipurpose pharmaceutical excipient
433
MYRRHA – A multi-purpose fast spectrum research reactor
434
MYRRHA: A multipurpose accelerator driven system for research & development
435
MYRRHA: A multipurpose accelerator driven system for research & development
436
MYRRHA: A multipurpose accelerator driven system for research & development
437
Myrtaceae revisited: a reassessment of infrafamilial group
438
Myrtenol Protects Against Acute Kidney Injury Induced by Cisplatin in Mice
439
Myrtle Ashmole and Philip Ashmole: The Carrifran Wildwood Story. Published by The Borders Forest Trust (2009). 223 pp., Price £15, paperback, ISBN: 978-0-9534346-4-0. Only available from: The Borders Forest Trust, Ancrum, Jedburgh, Scotland, TD8 6TU. .
440
Myrtle Essential Oil-Loaded Alginate Nanoparticles: A Dual Therapeutic Approach for Cytotoxicity Against Skin Cancer Cells and Antibacterial Effects on Common Pathogens
441
Myrtle hydroalcoholic extracts obtained from different selections of Myrtus communis L.
442
Myrtle McGrawʹs Neurobehavioral Theory of Development,
443
Myrtle McGrawʹs Unrecognized Conceptual Contribution to Developmental Psychology,
444
Myrtus communis L. as source of a bioactive and safe essential oil
445
MYRVIN HAROLD ELLESTAD, MD: a conversation with the editor
446
MySafeRx: a mobile technology platform integrating motivational coaching, adherence monitoring, and electronic pill dispensing for enhancing buprenorphine/naloxone adherence during opioid use disorder treatment: a pilot study
447
MYSELF, SPLIT OPEN: OVID, RUKEYSER, AND THE TRAUMATIC POETICS OF ORPHIC RE-MEMBERING
448
Mysids and trace metals: disruption of swimming as a behavioural indicator of environmental contamination
449
Mysovskii-type theorem for the Secant method under Hölder continuous Fréchet derivative
450
MYSS: should we alter clinical practice?
451
MYSS: should we alter clinical practice?
452
Mysteries of medulloblastoma yield to genomic researchers
453
Mysteries of morality
454
Mysteries of Motor Mechanics
455
Mysteries of the arc cathode spot: A retrospective glance
456
Mysteries of the Transferrin-Transferrin Receptor 1 Interaction Uncovered
457
Mysteries Unraveled by Channels Gone Awry
458
Mysteries, marvels, and mayhem of space on the Web
459
Mysterious attendance cycles in Coryʹs shearwater, Calonectris diomedea: an exploration of patterns and hypotheses
460
Mysterious brain disease kills eagles, ducks and coots in Eastern USA
461
Mysterious circles in the Namib Desert: review of hypotheses on their origin
462
Mysterious deaths of aquatic reptiles, with special emphasis on the Indian Flap-shelled turtle Lissemys punctata (Bonnaterre, 1789) from Gujarat State, India
463
Mysterious diel cycles of mercury emission from soils held in the dark at constant temperature
464
Mysterious episodic coma
465
Mysterious falls and a nasal voice
466
Mysterious fat. The different impact of fat content on toddlers’ and adults’ food intake
467
Mysterious ground states in the organic conductor α-(BEDT-TTF)2KHg(SCN)4 : Mixed SDW and CDW?
468
Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis
469
ʹMysteriousʹ moose disease in Sweden. Similarities to copper deficiency and/or molybdenosis in cattle and sheep. Biochemical background of clinical signs and organ lesions
470
Mysterious rectal bleeding in a female adolescent
471
Mystery and music from a talented medical student
472
Mystery at the museum
473
Mystery of Biphasic Defibrillation Waveform Efficacy: Is it Calcium?
474
Mystery of porous SnO2 thin film formation by pulsed delivery
475
Mystery of the Muse in Wallace Stevens The Idea of Order at Key West
476
Mystery of the rational iteration arising from relaxed Newton’s method
477
Mystery of the Silk Road
478
Mystery or Deviance: Sexology Discourse in Turkey Between 1930-60
479
Mystery pictures decoded
480
Mystery to mastery: the CSU Information Competence Project
481
Mystery, complexity, legibility and coherence: A meta-analysis
482
Mystical Analysis of Dream and its Effects in the Holy Quran
483
mystical analysis of the manifestation verse and its relationship with the spiritual journey
484
Mystical Chants in the Bajau Society: A Preliminary Observation on the Changes in the Mindset Towards the Planting Ritual
485
MYSTICAL ELEMENTS AND WORSHIP AMONG MALAY COMMUNITY IN PULAU BESAR, MELAKA
486
MYSTICAL POWERS OF WITCHCRAFT AMONG THE GBAGYIS
487
Mystification and social agent absences: a critical discourse analysis using evolutionary psychology
488
Myth and ceremony in workfare: rights, contracts, and client satisfaction
489
Myth and Media: Constructing Aboriginal Architecture
490
Myth and paradox of coronary risk and the menopause
491
Myth and Power
492
Myth and reality in the rain forest: how conservation strategies are failing West Africa By John F. Oates, 1999, University of California Press, 310 pp. ISBN 0-52022-252-0
493
Myth and reality of the hybrid desalination process Original Research Article
494
Myth and reality: A response to Lynn on the determinants of Italyʹs North–South imbalances
495
Myth and Science
496
Myth in the Holy Qur’an
497
Myth of market needs and technology seeds as a source of product innovation — an analysis of pharmaceutical new product development in an anti-hypertensive product innovation
498
Myth of symmetry: Public relations as cultural styles
499
Myth of the ideal cesarean section rate: Commentary and historic perspective
500
Myth of the menopause paradox
501
Myth or Reality: Self-Assessment Is Central to Effective Curriculum in Anatomical Pathology Graduate Medical Education
502
Myth or reality: The absence of evangelical Christian fiction titles in the public libraries of the United States
503
Myth or reality? Coexisting phonological disorders and stuttering
504
Myth, law and order: Schmitt and Benjamin read reflections on violence
505
Myth, magic, and the history of modern medicine
506
Myth, National Identity and Iranians Attitude towards International Relations
507
Myth, reality, and reform: higher education policy in Latin America: Claudio De Moura Castro and Daniel C. Levy; Inter-American Development Bank, Washington, D.C., 2000, pp. vi+116, price US $19.95 paperback
508
Myth-Centered Medicine in Ancient Greece and the Cognitive Effect Relationship between Medical Notions and Treatment Methods
509
Mythe, délire et psychiatrie. Essai dʹétude psychopathologique
510
Mythen detector system
511
Mythen detector system
512
MythenII: A 128 channel single photon counting readout chip
513
MythenII: A 128 channel single photon counting readout chip
514
Mythic Collaboration
515
Mythic Frodo and his Predestinate Call to Adventure
516
Mythological analysis of boating tourism
517
MYTHOLOGICAL ANALYSIS OF ỌJAADỊLỊ AND AKỤ FECHAA
518
MYTHOLOGICAL APPROACHES an‎d ARCHETYPES IN POST-9/11 HOLLYWOOD
519
Mythological Motifs in the Tauroctony Sculpture
520
Mythological Quests In Turkish Literature
521
Mythomania? Methods and morals from ‘The Myth of Language Universals’
522
Myths about cancer might interfere with screening decisions
523
Myths about later-day extensions of Darcyʹs law
524
Myths about spider envenomations and necrotic skin lesions
525
Myths About Surgical Myectomy: Rumors of Its Death Have Been Greatly Exaggerated
526
Myths about the treatment of addiction
527
Myths about workplace violence, harassment and bullying
528
Myths and facts about electricity in the U.S. South
529
Myths and legends as Malaysian tourism products: A case study of Lenggong Valley
530
Myths and misconceptions about student ratings of college faculty: Separating fact from fiction
531
Myths and Misconceptions of Wernicke’s Encephalopathy: What Every Emergency Physician Should Know
532
Myths and realities about the recovery of L׳Aquila after the earthquake
533
Myths and realities of academic labor markets
534
Myths and stereotypes of actors involved in domestic violence: Implications for domestic violence culpability attributions
535
Myths of Disaster Education: A Rebuttal
536
Myths of Electric Regulation: Looking at the Future of Energy through Entrepreneurial Eyes
537
Myths of skeptical environmentalism
538
Myths of slash and burn on physical degradation of savannah soils: impacts on Vertisols in north Cameroon
539
Myths regarding alternative fuel vehicle demand by light-duty vehicle fleets
540
Myths regarding exposure therapy for PTSD Original Research Article
541
Myths Regarding the NINDS rt-PA Stroke Trial: Setting the Record Straight
542
Myths, fables and even truths about warts and human papillomavirus
543
Myths, medicine, and meaning
544
Mytilopsis leucophaeata, an alien dreissenid bivalve discovered in the Gulf of Gdańsk (southern Baltic Sea)
545
Mytilus californianus as an indicator of heavy metals on the northwest coast of Baja California, Mexico
546
Mytilus galloprovincialis filter feeding on the bacterial community in a Mediterranean coastal area (Northern Ionian Sea, Italy
547
Mytilus galloprovincialis-type foot-protein-1 alleles occur at low frequency among mussels in the Dutch Wadden Sea
548
Myung-Gun Choo, The New Asia in Global Perspective
549
Myxedema psychosis with grade II hypothyroidism
550
Myxedema Psychosis: Neuropsychiatric Manifestations andRhabdomyolysis Unmasking Hypothyroidism
551
Myxing It Up to Study Chondramides
552
Myxobolus cerebralis (Myxozoa), the causative agent of whirling disease, reduces fecundity and feeding activity of Tubifex tubifex (Oligochaeta)
553
Myxobolus Spp. (Myxosporea: Myxobolidea) from fishes of the Zayandeh-rud River (Esfahan, Iran); new hosts and locality record.
554
Myxococcus xanthusʹ killed cells as inducers of struvite crystallization. Its possible role in the biomineralization processes
555
Myxofibrosarcoma of the Breast in a Young Pregnant Woman: A Case Report and Review of the Literature
556
Myxofibrosarcoma of the hypopharynx
557
Myxoglobulosis, A Rare Variant of Appendiceal Mucocele: Case Report and Review of the Literature
558
Myxoid Chondrosarcoma of Maxilla in a Pediatric Patient:A Rare Case Report
559
Myxoid liposarcoma: Sequences of the T(12; 16)(Q13; P11) from a primitive tumour
560
Myxoid Retroperitoneal Liposarcoma in a Patient with Personal and Family History of Different Cancers
561
Myxoid solitary fibrous tumour of the ischiorectal fossa
562
MYXOID VARIANT OF MALIGNANT FIBROUS HISTIOCYTOMA: A CASE REPORT
563
Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality
564
Myxoinflammatory fibroblastic sarcoma with complex supernumerary ring chromosomes composed of chromosome 3 segments
565
Myxoinflammatory fibroblastic sarcoma: a case report
566
Myxoma Immediately above the Junction of the Inferior Vena Cava and the Right Atrium: A Rare Cause of Budd-Chiari Syndrome
567
Myxoma in a Terrier Dog : a Case Report
568
Myxoma of the aortic valve
569
Myxoma of the Aortic Valve
570
Myxoma of the cornea
571
Myxoma of the right and left ventricles,A Case Report
572
Myxoma of the Superior Vena Cava Origin Presented as a Right Atrial Mass
573
Myxoma producing right-sided inflow and outflow obstruction
574
Myxoma Virus Immunomodulatory Protein M156R is a Structural Mimic of Eukaryotic Translation Initiation Factor eIF2α
575
Myxomatous embolization resulting in unilateral amaurosis
576
Myxomatous meningeal tumour: a case of “metastatic” cardiac myxoma
577
Myxomatous mitral valve disease and related entities: The role of matrix in valvular heart disease
578
Myxomycetes from Trabzon and Giresun Provinces (Turkey)
579
Myxomycetes in soil
580
Myxomycetes in soil
581
Myxopapillary Ependymoma of the Filum Terminale: Treatment and Outcome in 11 Cases
582
Myxopapillary ependymoma of the fourth ventricle
583
Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation
584
Myxosporeans (Phylum Myxozoa) Parasitic on Some Fishes from Tigris River at North, Mid and South of Baghdad Province, Iraq
585
Myxovirescin analogues via macrocyclic ring–closing metathesis
586
Mμ and D2 Receptor Antisense Oligonucleotides Injected in Nucleus Accumbens Suppress High Alcohol Intake in Genetic Drinking HEP Rats
587
Mω considered as a programming language Original Research Article
588
N
589
N - Commuting Maps on Semiprime Rings
590
N – Topological Space and Its Applications in Artificial Neural Networks
591
n + p → d + γ in effective field theory Original Research Article
592
N = 1 dual string pairs and gaugino condensation Original Research Article
593
N = 1 dual string pairs and their massless spectra Original Research Article
594
N = 1 dualities of SO and USp gauge theories and T-duality of string theory Original Research Article
595
N = 1 heterotic / M-theory duality and Joyce manifolds Original Research Article
596
N = 1 string duality
597
N = 1 super-Chern-Simons coupled to parity-preserving matter from Atiyah-Ward space-time
598
N = 1 supergravity BPS domain walls on Kähler–Ricci soliton
599
N = 1 superstring in 2 + 2 dimensions Original Research Article
600
N = 1 supersymmetric cosmic strings
601
N = 1 supersymmetric extension of the QCD effective action
602
N = 1 supersymmetric SU(4) × SU(2)L × SU (2)R effective theory from the weakly coupled heterotic superstring Original Research Article
603
N = 1 supersymmetry and the three-loop anomalous dimension for the chiral superfield Original Research Article
604
N = 1 supersymmetry and the three-loop gauge β-function
605
N = 1 super-τ3QED from Atiyah-Ward space-time
606
N = 1, D = 2 supermembrane in the coset approach
607
N = 1, D = 6 supergravity: Duality and non-minimal couplings Original Research Article
608
N = 2 curves and a Coulomb phase in N = 1 SUSY gauge theories with adjoint and fundamental matters
609
N = 2 extremal black holes and intersecting branes
610
N = 2 gauge theories on systems of fractional D3/D7-branes Original Research A
611
N = 2 heterotic string threshold correction, K3 surface and generalized Kac-Moody superalgebra
612
N = 2 heterotic superstring and its dual theory in five dimensions Original Research Article
613
N = 2 local and N = 4 non-local reductions of supersymmetric KP hierarchy in N = 2 superspace Original Research Article
614
N = 2 moduli spaces and N = 1 dualities for SO(nc) and USp(2nc) super-QCD Original Research Article
615
N = 2 rigid supersymmetry with gauged central charge Original Research Article
616
N = 2 super W∞ algebra and its nonlinear realization through super KP formulation
617
N = 2 super Yang-Mills and subgroups of SL(2,Z) Original Research Article
618
N = 2 super Yang-Mills low-energy effective action at two loops
619
N = 2 superconformal field theory with ADE global symmetry on a D3-brane probe Original Research Article
620
N = 2 supergravity Lagrangians with vector-tensor multiplets Original Research Article
621
N = 2 supersymmetric Calabi-Yau hypersurface sigma-models on curved two-dimensions
622
N = 2 supersymmetric gauge theories, branes and orientifolds Original Research Article
623
N = 2 Supersymmetric QCD and integrable spin chains: rational case Nf < 2Nc
624
N = 2 supersymmetry and Bailey pairs
625
N = 2 supersymmetry in a Chern-Simons system with the magnetic moment interaction
626
N = 2 supersymmetry of higher superspin massless theories
627
N = 2 topological Yang-Mills theories and Donaldsonʹs polynomials
628
N = 2 Type I-heterotic duality and higher derivative F-terms
629
N = 2 Type I-heterotic duality and higher derivative F-terms [Phys. Lett. B 395 (1997) 42]
630
N = 2 type II-heterotic duality and higher-derivative F-terms Original Research Article
631
N = 2 worldsheet instantons yield cubic self-dual Yang-Mills
632
N = 4 super NLS-mKdV hierarchies
633
N = 4 SYM on ∑ × S2 and its topological reduction Original Research Article
634
N = 4 topological strings Original Research Article
635
N = 4: a unifying framework for 2d topological gravity, cM ≤ 1 string theory and constrained topological sigma model
636
N = 8 BPS black holes with 12 or 14 supersymmetry and solvable Lie algebra decompositions Original Research Article
637
N = 8 gaugings revisited: an exhaustive classification Original Research Article
638
N → Δ electroproduction results from ELSA
639
N 2H +(1-0) survey of massive molecular cloud cores
640
n -3 Fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans.
641
N Acetyl Cysteine, A novel Remedy for Poly Cystic Ovarian Syndrome
642
N Acetyl Cysteine, A novel Remedy for Poly Cystic Ovarian Syndrome
643
n advanced fuzzy controller
644
N and C mineralization in soil amended with the N immobilization inhibitor, methionine sulphoximine
645
N and C mineralization in soil amended with the N immobilization inhibitor, methionine sulphoximine
646
N- and C-terminal modifications of negamycin
647
N and C-terminal Sub-regions in the c-Myc Transactivation Region and their Joint Role in Creating Versatility in Folding and Binding Original Research Article
648
N- and Mo-doping Bi2WO6 in photocatalytic water splitting
649
N and N,S-doped TiO2 photocatalysts and their activity in NOx oxidation
650
N and p doped poly(3,4-ethylenedioxythiophene) electrode materials for symmetric redox supercapacitors
651
N and P dynamics in the litter layer and soil of Mexican semi-arid forests, state of Morelos
652
N and P leaching and microbial contamination from intensively managed pasture and cut sward on sandy soil in Finland
653
n- and p-Channel field-effect transistors based on diquinoxalinoTTF derivatives
654
N and p-type doping of PECVD a-SiC:H obtained under “silane starving plasma” condition with and without hydrogen dilution
655
N atoms recombination on a silica surface: A global theoretical approach
656
N balance as an indicator of N leaching in an oilseed rape – winter wheat – winter barley rotation
657
N biochemical diversity as a factor of soil diversity
658
N biochemical diversity as a factor of soil diversity
659
N -BIT PARITY NEURAL NETWORKS WITH MINIMUM NUMBER OF THRESHOLD NEURONS
660
N budget as water quality management tool in closed aquatic mesocosms
661
N -carboxymethyllysine formation by direct addition of glyoxal to lysine during the Maillard reaction
662
N deficiency in a well-oxygenated cold bottom water over the Bering Sea shelf: influence of sedimentary denitrification
663
N Degrees of Separation: Influences of Dynamic Programming on Computer Science
664
N dopant induced antiferromagnetism in anatase TiO2 : First principle study
665
N dynamics and sources of N2O production following pig slurry application to a loamy soil
666
N dynamics in the rhizosphere of Pinus ponderosa seedlings
667
N dynamics in the rhizosphere of Pinus ponderosa seedlings
668
N EWTON : An Interactive Environment for Exploring Mathematics
669
n examination of strategic goals and management practices of Russian enterprises
670
N fluxes in an agricultural catchment under monsoon climate: A budget approach at different scales
671
n Focus: Featured Articles in This Monthʹs Animal Behaviour
672
n fuzzy type theory
673
N -FUZZY UP-ALGEBRAS AND ITS LEVEL SUBSETS
674
N identical particles under quantum confinement: a many-body dimensional perturbation theory approach
675
n improved family of ZVS-PWM active-clamping DC-to-DC converters
676
N incorporation and electronic structure in N-doped TiO2(1 1 0) rutile
677
N incorporation, composition and electronic structure in N-doped TiO2(0 0 1) anatase epitaxial films grown on LaAlO3(0 0 1)
678
N leaching to groundwater from dairy production involving grazing over the winter on a clay-loam soil Original Research Article
679
N mineralization and nitrate leaching from vegetable crop residues under field conditions: a model evaluation
680
N mineralization and nitrate leaching from vegetable crop residues under field conditions: a model evaluation
681
n observation instrument for assessment of work technique n patient transfer tasks
682
N parallel queueing systems with server breakdown and repair
683
n properties of solutions to the improved modified Boussinesq equation
684
n search of practical applications: A public services research agenda for university libraries
685
n search of the liquidity effect in Ukraine
686
n the frame of globalization and sustainability, process intensification, a path to the future of chemical and process engineering (molecules into money
687
n the second part of Hilbertʹs 16th problem
688
n the well-foundedness of adequate orders used for construction of complete unfolding prefixes
689
n- to p- type carrier reversal in nanocrystalline indium doped ZnO thin film gas sensors
690
N umerical analyses of the impact of plates for thermal stratification inside a storage tank with upper and lower inlet flows
691
N uptake and yield of wheat as influenced by integrated use of organic and mineral nitrogen
692
N- versus P-co-ordination for N–B and P–B bonded BH3 adducts for various phosphinamine ligands – An experimental and computational study
693
n vivo motion of the rectus femoris muscle after tendon transfer surgery
694
N- vs O-Coordination in cyclomanganation of 1,5-diaryl-3-(2-pyridyl)pentane-1,5-diones and 3-(2-pyridyl)chalcones; cyclomanganation at saturated carbon and the crystal structure of [1,5-diphenyl-κC2-3-(2-pyridyl- κN)pentan-2-yl-κC2-1,5-dione-κO1κO5]tetrac
695
N- WAY COMPACT ULTRA-WIDE BAND EQUAL AND UNEQUAL SPLIT TAPERED TRANSMISSION LINES WILKINSON POWER DIVIDER
696
n -weak amenability of a certain class of function spaces
697
n α-solvable fundamental groups
698
N + 1 redundancy on ATCA instrumentation for Nuclear Fusion
699
N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)
700
N-(1,2-Diphenylethyl)piperazines: A new class of dual serotonin/noradrenaline reuptake inhibitor
701
N-(15,16-Dihydroxylinoleoyl)-glutamine and N-(15,16-epoxylinoleoyl)-glutamine isolated from oral secretions of lepidopteran larvae
702
N-(1-Benzylpyrrolidin-3-yl)arylbenzamides as potent and selective human dopamine D4 antagonists
703
N-(1-Carboxyethyl)alanine (alanopine), a new non-sugar component of lipopolysaccharides of Providencia and Proteus
704
N-(1-phenyl-2-benzimidazolyl)-N′-phenylurea derivatives as potent in hibitors of acylcoa:cholesterol acyltransferase (ACAT)
705
N-(2-(2-pyridyl)ethyl)chitosan: Synthesis, characterization and sorption properties
706
N-(2-(4-hydroxyphenyl)ethyl)-4-chlorocinnamide: A novel antagonist at the 1 /2B NMDA receptor subtype
707
N-(2,2-Dimethyl-2-(2-nitrophenyl)acetyl)-4-aminocyclophosphamide as a potential bioreductively activated prodrug of phosphoramide mustard
708
N-(2,2-Diphenylvinyl)-N,N′-diphenylbenzidine-based derivatives as hole-transporting glass-forming materials
709
N-(2′,5′-di-t-butylphenyl)-4-ethoxy-1,8-naphthalimide: A new fluorophore highly efficient for fast neutrons/gamma-rays discrimination in liquid media
710
N-(2′,5′-di-t-butylphenyl)-4-ethoxy-1,8-naphthalimide: A new fluorophore highly efficient for fast neutrons/gamma-rays discrimination in liquid media
711
N-(2-Acetamido-2-de­­oxy-β-D-gluco­pyranos­yl)-N-(3-azido­prop­yl)-O-methyl­hydroxyl­amine
712
N-(2-Alkoxyphenyl)-substituted double rhodanine indoline dyes for zinc oxide dye-sensitized solar cell
713
N-(2-Amino-phenyl)-4-(heteroarylmethyl)-benzamides as new histone deacetylase inhibitors
714
N-(2-Anthracene)methacrylamide: a new fluorogenic probe molecule for monitoring in situ the radiation-induced polymerization of methyl methacrylate in bulk and in solution
715
N-(2-Benzoylphenyl)benzamido nickel(II) complexes and polymerization reactivity
716
N-(2-biphenylenyl)-4-[2′-phenylethynyl]phthalimide—new monomer synthesis, cure and thermal properties of resulting high temperature polymer
717
N-(2-bromotetrafluoroethyl) derivatives of five-membered nitrogen-containing heterocycles
718
N-(2-Carboxyethyl)chitosans: regioselective synthesis, characterisation and protolytic equilibria Original Research Article
719
N(2D) in nitrogen afterglow
720
N-(2-formyl-1-methylimidazol-4-yl)-2,2-dimethylpropanamide: a versatile reagent for preparing imidazole-amine ligands with variable second-coordination spheres
721
N-(2-hydroxypropyl)-3-trimethylammonium chitosan-poly(ɛ-caprolactone) copolymers and their antibacterial activity
722
N-(2-Hydroxypropyl)formamide and N-(2-hydroxyethyl)-N-methylformamide as two new plasticizers for thermoplastic starch
723
N-(2-Hydroxypropyl)formamide and N-(2-hydroxyethyl)-N-methylformamide as two new plasticizers for thermoplastic starch
724
N-(2-pyridylmethyl)-L-histidine functionalized Fe3O4 magnetic nanoparticles as an efficient catalyst for synthesis of β-amino ketones
725
N-(2-pyrrolidinylmethyl)benzoxazine-8-carboxamides exhibiting high affinities for All of D2, 5-HT1 A, and 5-HT2 receptors
726
N-(3-(4-Hydroxyphenyl)-propenoyl)-amino acid tryptamides as SIRT2 inhibitors
727
N-(3-(Phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: Structure, synthesis and SAR
728
N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics Original Research Article
729
N-(3-Acyloxy-2-Benzylpropyl)-N′-Dihydroxytetrahydrobenzazepine and Tetrahydroisoquinoline Thiourea Analogues as Vanilloid Receptor Ligands Original Research Article
730
N-(3-Benzo[b]thienyl)iminophosphoranes toward the Synthesis of Benzo[b]thieno[3,2-b]pyridines: Reactivity and Alternative Regioselectivity with α,β-unsaturated Ketones and Aldehydes
731
N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3
732
N-(3-Iodophenyl)trozamicol (IPHT) and Related Inhibitors of Vesicular Acetylcholine Transport: Synthesis and Preliminary Biological Characterization
733
N-(3-Phenylsulfonyl-3-piperidinoyl)-phenylalanine derivatives as potent, selective VLA-4 antagonists
734
N-(3-Triethoxysilylpropyl)-4-(isothiocyanatomethyl)-cyclohexane-1-carboxamide (TPICC): A heterobifunctional reagent for immobilization of biomolecules on glass surface
735
N-(3-Triethoxysilylpropyl)-4-(N′-maleimidylmethyl)cyclohexanamide (TPMC): A heterobifunctional reagent for immobilization of oligonucleotides on glass surface
736
N-(3-Trifluoroethanesulfonyloxypropyl)anthraquinone- 2-carboxamide: A New Heterobifunctional Reagent for Immobilization of Biomolecules on a Variety of Polymer Surfaces
737
N-(4-(4-Chlorophenyl)Thiazol-2-yl)-2-(2-Phenylacetamido) Acetamide Derivatives as Potential Anticancer Agents: Synthesis and Cytotoxicity Evaluation
738
N-(4-(di-tert-butyl[18F]fluorosilyl)benzyl)-2-hydroxy-N,N-dimethylethylammonium bromide ([18F]SiFAN+Br−): A novel lead compound for the development of hydrophilic SiFA-based prosthetic groups for 18F-labeling
739
N-(4-(quinazolin-2-yl)phenyl)benzamide derivatives with potent anti-angiogenesis activities: synthesis and evaluation
740
N-(4-{[4-(1H-Benzoimidazol-2-yl)-arylamino]-methyl}-phenyl)-benzamide derivatives as small molecule heparanase inhibitors
741
N-(4-Bromobenzoyl)-S,S-dimethyliminosulfurane, a potent dermal penetration enhancer
742
N-(4-hydroxyphenyl)retinamide (4-HPR) modulates GADD45 expression in radiosensitive bladder cancer cell lines
743
N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-γ sensitivity for apoptosis in human glioblastoma cells
744
N-(4-hydroxyphenyl)retinamide-induced death in human lymphoblastoid cells: 50 kb DNA breakage as a means of distinguishing apoptosis from necrosis
745
N-(5-Chloro-2-(hydroxymethyl)-N-alkyl-arylsulfonamides as γ-secretase inhibitors
746
N-(5-Mercapto-1,3,4-Thiadiazol-2-yl)-2-Phenylacetamide Derivatives: Synthesis and In-vitro Cytotoxicity Evaluation as Potential Anticancer Agents
747
N-(5-substituted) thiophene-2-alkylsulfonamides as potent inhibitors of 5-lipoxygenase Original Research Article
748
N-(6- F-18Fluorohexyl)-N-Methylpropargylamine: A Fluorine-18-Labeled Monoamine Oxidase B Inhibitor for Potential Use in PET Studies
749
N-(6,7-Dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-d-aspartate receptor antagonists for the treatment of pain
750
N-(6-Methyl-2-pyridyl)acrylamide: a case of amide hydrolysis without the assistance of acid or base in the synthesis of water-driven H-bonded polymeric chains
751
N(7)-protonation-induced conformational flipping in hypermodified nucleic acid base N6-(N-glycylcarbonyl) adenine
752
N-(Aryl)-4-(azolylethyl)thiazole-5-carboxamides: Novel potent inhibitors of VEGF receptors I and II
753
N-(Arylacetyl)-biphenylalanines as Potent VLA-4 Antagonists
754
N-(Benzoyloxy)amines: an investigation of their thermal stability, synthesis, and incorporation into novel peptide constructs
755
N-(carbobenzyloxy)isatin: A slow binding α-keto lactam inhibitor of α-chymotrypsin
756
N-(Cyclohexanecarboxyl)-O-Phospho-l-Serine, a Minimal Substrate for the Dual-Specificity Protein Phosphatase IphP
757
N-(Diethoxyphosphoryl)-O-benzylhydroxylamine—a convenient substrate for the synthesis of N-substituted O-benzylhydroxylamines
758
N-(ethoxycarbonyl)ferrocenecarboxamide: Synthesis and use as the pronucleophile in the Mitsunobu reaction
759
N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A Original Research Article
760
N-(Indol-3-ylglyoxylyl)piperidines: high affinity agonists of human GABA-A receptors containing the α1 subunit
761
N(k)-quasi Einstein manifolds satisfying certain conditions
762
N(k)-Quasi Einstein manifolds satisfying certain curvature conditions
763
N-(n-benzylpiperidin-4-yl)-2-[18f]fluorobenzamide: a potential ligand for pet imaging of breast cancer
764
N-(o-Aminophenyl)-2-oxy-4-methoxybenzophenoneimine – Si-chelation by a tridentate ONN ligand system versus benzimidazoline formation
765
N(omega) and (delta)(omega) dibaryons in a SU(3) chiral quark model
766
N-(p-Ethynylbenzoyl) derivatives of amino acid and dipeptide methyl esters – Synthesis and structural study
767
N-(Phenylselenomethyl)phthalimide as new reagent for mild protection of alcohols as Pim-ethers
768
N-(phenylsulfonyl)-glycine — A new contaminant in sewage- and surface water
769
N-(Piperidinomethyl)-3-[(pyridylidene)amino]isatin: A new and effective acid corrosion inhibitor for mild steel
770
N-(Propargyl)diazenecarboxamides for ‘click’ conjugation and their 1,3-dipolar cycloadditions with azidoalkylamines in the presence of Cu(II)
771
N-(Pyrimidin-4-yl) and N-(Pyridin-2-yl) phenylalanine derivatives as VLA-4 integrin antagonists
772
N-(Quinuclidin-3-yl)-2-(1-methyl-1H-indol-3-yl)-2-oxo-acetamide: a high affinity 5-HT3 receptor partial agonist
773
N-(substituted-phenyl) piperazines: antagonists with high binding and functional selectivity for dopamine D4 receptors
774
N-(sulfoethyl) iminodiacetic acid-based lanthanide coordination polymers: Synthesis, magnetism and quantum Monte Carlo studies
775
N-(Sulfonamido)alkyl[tetrahydro-1H-benzo[e]indol-2-yl]amines: potent antagonists of human neuropeptide Y Y5 receptor
776
N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds
777
N-(trans-1-Propenyl)carbazole: an excellent dienophile for cation radical Diels–Alder cycloadditions
778
N-(Trifluoromethyl)benzyl substituted N-Normetazocines and N-Norketobemidones Original Research Article
779
N-(Trifluoromethylsulfonyl)trifluoromethanesulfinimidic acid and its salts
780
N(α)-histogram analysis of the ventricular fibrillation ECG-signal as predictor of countershock success
781
N-(α-Amidoalkyl)benzotriazole-mediated synthesis of β′-amido β-diketones: a general synthetic protocol for N-[β-(3,5-di and 1,3,5-trisubstituted pyrazol-4-yl)alkyl] amides
782
N-(β-Elemene-13-yl)tryptophan methyl ester induces apoptosis in human leukemia cells and synergizes with arsenic trioxide through a hydrogen peroxide dependent pathway
783
N* and Δ* parity doublets in the baryon spectrum
784
N*(1440) decays in a hybrid baryon model Original Research Article
785
N*N multiwavelength optical cross-connect based on tunable fiber Bragg gratings
786
N, Ar and Pb isotopic co-variations in magmatic minerals: Discriminating fractionation processes from magmatic sources in Monteregian Hills, Québec, Canada
787
N, N-dimethylacetamide/lithium chloride plasticized starch as solid biopolymer electrolytes
788
N, N-dimethylacetamide/lithium chloride plasticized starch as solid biopolymer electrolytes
789
N, O-ligand accelerated zinc-catalyzed transesterification of alcohols with vinyl esters
790
N, P and K budgets for crop rotations on nine organic farms in the UK
791
N, P and K limitation of fine root growth along an elevation transect in tropical mountain forests
792
N, S co-doped and N-doped Degussa P-25 powders with visible light response prepared by mechanical mixing of thiourea and urea. Reactivity towards E. coli inactivation and phenol oxidation
793
N, S co-doped-TiO2/fly ash beads composite material and visible light photocatalytic activity
794
N, S-Codoped TiO2/Fe2O3 Heterostructure Assemblies for Electrochemical Degradation of Crystal Violet Dye
795
N, S-doped TiO2 anode effect on performance of dye-sensitized solar cells Original Research Article
796
N-, α-, and β-Substituted 3-Aminopropionic acids: design, syntheses and antiseizure activities Original Research Article
797
N,3,4-Trisubstituted pyrrolidines by electron transfer-induced oxidative cyclizations of N-allylic β-amino ester enolates
798
N,N,N ,N -tetramethylethylene-diaminium-N,N -disulfonic acid chloride as a highly effective catalyst for the synthesis of 4H-pyrano[2, 3-c]pyrazoles, α-carbamatoalkyl-β-naphthols and α-amidoalkyl-β-naphthols
799
N,N,N,N-tetramethylethane-1,2-diamine complexes of vanadium chlorides
800
N,N,N,N-Tetramethylguanidinium acetate as an efficient and reusable ionic liquid catalyst for the one-pot synthesis of dihydropyrrol-2-ones
801
N,N,N’,N’-TetramethylN,N’-bis(sulfo)ethane-1,2- Diaminium Mesylate ‎as a Highly Effective and Dualfunctional Catalyst for the Synthesis of 1-Thioamidoalkyl-2-naphthols
802
N,N,N′,N′-Tetraethylchloroformamidinium chloride, the first acyclic diaminocarbene–Cl2 adduct
803
N,N,N′,N′-Tetrakis(2-hydroxyethyl)ethylenediamine palladium(II) complex as efficient catalyst for the Suzuki/Miyaura reaction in water
804
N,N,N′,N′-Tetramethyl-1,3-propanediamine as the catalyst of choice for the Baylis–Hillman reaction of cycloalkenone: rate acceleration by stabilizing the zwitterionic intermediate via the ion–dipole interaction
805
N,N,N′,N′-Tetramethylethylendiamine adducts of amido calcium bases – Synthesis of monomeric [(tmeda)Ca{N(SiMe3)2}2], [(tmeda)Ca{NiPr2}2], and dimeric Hauser base-type [(tmeda)Ca(tmp)(μ-I)]2 (tmp = 2,2,6,6-tetramethylpiperidide)
806
N,N,N′-Trialkyl-1,8-diaminonaphthalenes: convenient method of preparation from protonated proton sponges and the first X-ray information
807
N,N,N-trimethyl chitosan nanoparticles as a vitamin carrier system
808
N,N,N-Trimethyl chitosan nanoparticles for controlled intranasal delivery of HBV surface antigen
809
N,N,N-Trimethyl chitosan nanoparticles for the delivery of monoclonal antibodies against hepatocellular carcinoma cells
810
N,N’-Hexadecanoyl l-2-diaminomethyl-18-crown-6 surfactant: Synthesis and aggregation features in aqueous solution
811
N,N′ and N,O chelated phosphenium cations containing aminotroponiminate or aminotroponate units
812
N,N′,N″-Tri-Boc-guanidine (TBG): a common starting material for both N-alkyl guanidines and amidinoureas
813
N,N′,N″-Triphenylguanidinate(−1) complexes of ruthenium, osmium and iridium: synthesis and X-ray crystal structures
814
N,N′-Bis-(1H-benzimidazol-2-yl)-isophthalamide as an additive in sulfonated polymer membranes for direct methanol fuel cells
815
N,N′-bis(2-hydroxy-3-methoxybenzylidene)-1,3-diaminopropane dimeric 4f and 3d–4f heterodinuclear complexes: Syntheses, crystal structures and magnetic properties
816
N,N′-Bis(3-aminopropyl)-2,7-diamino-1,8-naphthyridine stabilized a single pyrimidine bulge in duplex DNA Original Research Article
817
N,N′-Bis(3-methoxysalicylidene)propane-1,2-diamine mononuclear 4f and heterodinuclear Cu-4f complexes: Synthesis, crystal structure and electrochemical properties
818
N,N′-Bis(3-methyl-1-phenyl-4-benzylidine-5-pyrazolone)propylenediamine Schiff base as a neutral carrier for silver (I) ion-selective electrodes
819
N,N′-Bis(pyridin-3-ylmeth­yl)ethanedi­amide monohydrate: crystal structure, Hirshfeld surface analysis and computational study
820
N,N′-Bis(pyridin-4-ylmeth­yl)oxalamide benzene monosolvate: crystal structure, Hirshfeld surface analysis and computational study
821
N,N′-bis(salicylidene)propane-1,2-diamine lanthanide(III) coordination polymers: Synthesis, crystal structure and luminescence properties
822
N,N′-bis(substituted-phenyl)oxamides and their dinuclear pentacoordinate nickel(II) complexes
823
N,N′-Bis[2,6-bis­­(1-methyl­eth­yl)phen­yl]pyridine-4-carboximidamide toluene hemisolvate
824
N,N′-Bis[4-(N-alkylamidino)phenyl]homopiperazines as anti-Pneumocystis carinii agents
825
N,N′-Carbonyldiimidazole-mediated functionalization of superparamagnetic nanoparticles as vaccine carrier
826
N,N′-Dialkylated 1,2-diamine derivatives as new efficient ligands for RuCl2(PPh3)3 catalyzed asymmetric transfer hydrogenation of aromatic ketones
827
N,N′-Diaminoethane linked bis-TEMPO-mediated free radical polymerization of styrene
828
N,N′-Diarylcyanoguanidines as antagonists of the CXCR2 and CXCR1 chemokine receptors
829
N,N′-Dichloro bis(2,4,6-trichlorophenyl)urea (CC-2): an efficient reagent for the synthesis of α-chloro-nitroso compounds
830
N,N′-Dichlorobis(2,4,6-trichlorophenyl)urea (CC-2) as a new reagent for the synthesis of pyrimidone and pyrimidine derivatives via Biginelli reaction
831
N,N′-Dimethylpiperazine mono-betaine complex with two molecules of 3-iodobenzoic acid and water studied by X-ray diffraction, DFT, FTIR and NMR methods
832
N,N′-Dioxide–nickel(II) complex catalyzed asymmetric Michael addition of cyclic 1,3-dicarbonyl compounds to β,γ-unsaturated α-ketoesters
833
N,N′-Dioxide–scandium(III) complex catalyzed highly enantioselective Friedel–Crafts alkylation of indole to alkylidene malonates
834
N,N′-Diphenylthioureido complexes of ruthenium, osmium and iridium
835
N,N′-dipropyl, N,N′-bis(4-methyl benzene sulfonyl) hydrazide: a new radical source for chain polymerization of vinyl monomers
836
N,N′-disalicylidene-1,3-diaminopropane as a selective chelating titrant for copper(II)
837
N,N′-disalicylidene-1,3-diaminopropane as a selective chelating titrant for copper(II)
838
N,N′-Disubstituted phenanthrene-9,10-diimines: synthesis and NMR spectroscopic study
839
N,N′-Ethylene-bis(3-methoxysalicylideneimine) mononuclear (4f) and heterodinuclear (3d–4f) metal complexes: Synthesis, crystal structure and luminescent properties
840
N,N′-Ethylenediaminobis(benzylphosphonic acids) as a potent class of chelators for metal ions
841
N,N′-Linked 1,2-benzisothiazol-3(2H)-one 1,1-dioxides: synthesis, biological activity, and derived radicals
842
N,N′-Mono substituted acyclic thioureas: efficient ligands for the palladium catalyzed Heck reaction of deactivated aryl bromides
843
N,N-6-bis-[2-(3,4-dihydroxybenzyl)pyrrolidinyl]hexane, a potent, selective, orally active dopamine analog with hypotensive and diuretic activity
844
N,N-Bis(2,2-diphenylvinyl)anilines as new effective glass-forming hole transport materials for electrophotographic photoreceptors
845
N,N-bis(quinonyl)amines; synthesis and X-ray structure
846
N,N-Diacetylsialyl chloride—a novel readily accessible sialyl donor in reactions with neutral and charged nucleophiles in the absence of a promoter Original Research Article
847
N,N-dialkyl perfluoroalkanesulfonamides: Synthesis, characterization and properties
848
N,N-Dialkyl-4-[(8-azabicyclo[3.2.1]-oct-3-ylidene)phenylmethyl]benzamides, potent, selective δ opioid agonists
849
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitors
850
N,N-Dialkylcarbamato derivatives of niobium and tantalum as precursors to metal-functionalized silica surfaces
851
N,N-dialkylcarbamato metal complexes, molecular inorganic precursors to functionalized inorganic matrices
852
N,N-Dialkylcarbamato μ-oxo derivatives of iron(III)
853
N,N-Dialkyl-dipeptidylamines as novel N-type calcium channel blockers
854
N,N-dialkylimidazolium dialkylphosphate ionic liquids: Their extractive performance for thiophene series compounds from fuel oils versus the length of alkyl group
855
N,N-Dibenzyl-N′-benzylidenehydrazines: Potent Competitive Glucose-6-phosphatase Catalytic Enzyme Inhibitors
856
N,N-Dichloro poly(styrene-co-divinyl benzene) sulfonamide polymeric beads: an efficient and recyclable reagent for the synthesis of dialkyl chlorophosphates from dialkylphosphites at room temperature
857
N,N-dicyclohexylcarbodiimide assisted synthesis and characterization of poly(vinyl alcohol-co-vinyl levulinate)
858
N,N-diethyl-m-toluamide transformation in river water Original Research Article
859
N,N-Difluoro-O-trifluoromethyl-hydroxylamine, CF3ONF2: conformation and vibrational analysis studied by experimental and theoretical methods
860
N,N-Difluoro-O-trifluoromethyl-hydroxylamine, CF3ONF2: conformation and vibrational analysis studied by experimental and theoretical methods
861
N,N-Dimethyl-2,3-dialkylpyrazinium salts as redox-switchable surfactants? Redox, spectral, EPR and surfactant properties
862
N,N-dimethylaminoethylaminoanthrone – A chromofluorogenic chemosensor for estimation of Cu2+ in aqueous medium and HeLa cells imaging
863
N,N-Dimethylaniline and 1-(trifluoromethyl)benzene-functionalized tetrakis(ethynyl)pyrenes: synthesis, photophysical, electrochemical and computational studies
864
N,N-Dimethylbiguanide immobilized on mesoporous and magnetically separable silica: Highly selective and feasible organocatalyst for synthesis of B-nitroalcohols
865
N,N-dimethylcarbamato complexes of zinc
866
N,N-Dimethylformamide: much more than a solvent
867
N,N-Dimethylformamide-stabilized palladium nanoclusters as catalyst for Migita–Kosugi–Stille cross-coupling reactions
868
N,N-Dimethyl-S-difluoromethyl-S-phenylsulfoximinium tetrafluoroborate: A versatile electrophilic difluoromethylating reagent
869
N,N-Di-n-octyl-N,N-dimethyl and N,N-di-n-nonyl-N,N-dimethyl ammonium cholates: 13C and 15N CPMAS NMR, powder X-ray diffraction and thermoanalytical characterization
870
N,N-Disubstituted Aminomethyl Benzofuran Derivatives: Synthesis and Preliminary Binding Evaluation Original Research Article
871
N,N-Disubstituted piperazines: synthesis and affinities at α4β2* and α7* neuronal nicotinic acetylcholine receptors
872
N,N-Disubstituted propargylamines as tools in the sequential 1,3-dipolar cycloaddition/arylation processes to the formation of polyheterocyclic systems
873
N,O versus O,O coordination in β-imino diketonato complexes: Role of the metal center and of the imino substituent
874
N,O6-partially acetylated chitosan nanoparticles hydrophobically-modified for controlled release of steroids and vitamin E
875
N,O-Bis-(ethoxycarbonyl)hydroxylamine: a convenient reagent for the Lossen transformation
876
N,O-Chelate complexes of Ru(II), Ir(III), Pd(II), Pt(II) and Cu(II) with tetrahydroisoquinolinic acid. Molecular structures of [(Et3P)(Cl)M(OOCCHCH2C6H4CH2NH)], M=Pd, Pt
877
N,O-chelating bidentate Ni (II) and Pd (II) complexes for copolymerization of norbornene and norbornene ester
878
N. Avdan Boyacigiller, R. Alan Goodman and M.E. Phillips, Editors, Crossing Cultures: Insights from Master Teachers, Routledge, New York (2004).
879
N. Cameron, N.G. Norgan and G.T.H. Ellison, Childhood Obesity: Contemporary Issues, CRC Taylor & Francis, Boca Raton, Florida (2006) ISBN 0-8493-2857-8.
880
N. De Genova and A.Y. Ramos-Zayas, Latino crossings: Mexicans, Puerto Ricans and the politics of race and citizenship, Routledge, New York (2003) ISBN 0415-93457-5 257 pp. Paper $25.95.
881
N. E. Fancey, I. D. Gardner and R. A. Vaughan, The Determination of Geophysical Parameters from Space. Proceedings of the 43rd Scottish Universities Summer School in Physics, Dundee, August–September 1994. A NATO ASI.T
882
N. Evans, D. Campbell and G. Stonehouse, Strategic Management for Travel & Tourism, Elsevier, Oxford (2003) ISBN 0750648546 (401pp., (Pbk)).
883
N. Freymond and G. Cameron, Editors, Towards Positive Systems of Child and Family Welfare: International Comparisons of Child Protection, Family Service, and Community Caring Systems, University of Toronto Press, Toronto, Ontario (2006) 360 pp..
884
N. Fujisawa, G. Takeda and N. Ike
885
N. Hilal, M. Khayet, C.J. Wright (Eds.), Membrane Modification: Technology and Applications, CRC Press, Taylor & Francis Group, Boca Raton, London, New York, pp. 492.
886
N. J. Abboud, M. Sakawa, M. Inuiguchi
887
N. Leiper, Tourism management (Third Ed.), Frenchs Forest, NSW, Pearson Education Australia (2004) ISBN 1862505330 pp. 445 (pbk).
888
N. Magan, M. Olsen (Eds.), Mycotoxins in Food. Detection and Control. CRC Press, New York, Woodhead Publishing, Cambridge, England, 2004, xxvi + 471 pages, hardback; CRC Press ISBN 0-8493-2557-9, order no. W2557; US$ 225.00/€ 190.00/GB £ 135.00;
889
N. Magan, M. Olsen (Eds.), Mycotoxins in Food—Detection and Control, CRC Press, Boca Raton, Boston, New York, Washington, DC/Woodhead Publishing Limited, Cambridge, England, 2004, 471 pages, hardcover, price £135, ISBN 0-8493-2557-9.
890
N. Northcutt and D. McCoy, Interactive qualitative analysis: A systems method for qualitative analysis, Sage Publications (2004) ISBN 0-7619-2833-2.
891
N. Solomon, War Made Easy: How Presidents and Pundits Keep Spinning Us to Death, John Wiley & Sons, Hoboken, NJ (2005) 314 pp., Price: US$ 24.95.Y.R. Kamalipour and N. Snow, Editors, War, Media, and Propaganda: A Global Perspective, Rowman & Littlefield,
892
N. Stern Daniel, The Present Moment. In Psychotherapy and Everyday Life, W.W. Norton & Co., New York, London (2004) 283 pages, hard, $29.95.
893
N. Vanhove, The Economics of Tourism Destinations, Butterworth–Heinemann, Oxford (2005) ISBN 0-7506-6637-4 (251pp., £34.99 Hardback).
894
N.C. Andreasen, Brave New Brain: Conquering Illness in the Era of the Genome (2004) Price: £9.99, ISBN: 0-19-516728-7.
895
N.E.W.S.: A model for the evaluation of non-life insurance companies
896
N.H. co-op offers $1.4 bn. for NUʹs troubled PSNH unit
897
N.H. retail access advances
898
N.H. retail wheeeling experiment gets a boost
899
N.J. Nilsson, Artificial Intelligence: A New Synthesis T. Dean, J. Allen and Y. Aloimonos, Artificial Intelligence: Theory and Practice D. Poole, A. Mackworth and R. Goebel, Computational Intelligence: A Logical Approach S. Russell and P. Norvig, Artifici
900
N.J. Russell, G.W. Gould (Eds.), Food Preservatives, second edition, Kluwer Academic/Plenum Publishers, New York, 2003, ISBN: 0-306-44736-X ($165, 380pp.).
901
N.J.-N.Y. co-op wants to drop allegheny G&T
902
N.V. Varghese, Editor, Private Higher Education, UNESCO International Institute for Educational Planning, Paris (2004) ISBN 92-803-1272-3 (pbk) (Policy Forum No. 16, 252pp.).
903
N.W. makes serious run at an ISO—but whereʹs BPA?
904
N.Y. utilities file restructure plans, but sue to stop PSC
905
N/C-4 substituted azetidin-2-ones: Synthesis and preliminary evaluation as new class of antimicrobial agents
906
n/p-Type changeable semiconductor TiO2 prepared from NTA
907
N/sub 2/-incorporation-induced blue shift in InGaAsN/GaAs quantum well during annealing
908
N/Zr-codoped TiO2 nanotube arrays: Fabrication, characterization, and enhanced photocatalytic activity
909
n: Bruce L. Bowerman, Richard T. OʹConnell and Anne B. Koehler, Editors, Forecasting, time series, and regression: an applied approach (4th edition), Duxbury Press (2005) ISBN 0-534-40977-6 686 pages.
910
n: J.D. Wiskerke and J.D. van der Ploeg, Editors, Seeds of Transition: Essays on Novelty Production, Niches and Regimes in Agriculture, Royal van Gorcum, Assen Netherlands (2004) (356 pp., € 35, ISBN 90-232-3988-1).
911
N:Si ratios and the ‘balance of organisms’: PROWQM simulations of the northern North Sea
912
N@C60 as a structural probe for fullerene nanomaterials
913
N-[(3S)-1-Benzylpyrrolidin-3-yl]-(2-thienyl)benzamides: Human dopamine D4 ligands with high affinity for the 5-HT2A receptor
914
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist
915
N-[1-(2-Phenylethyl)pyrrolidin-3-yl]-1-adamantanecarboxamides as novel 5-HT2 receptor antagonists
916
N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo Original Research Article
917
N-[18F]fluoroethylpiperidin-4-ylmethyl butyrate: a novel radiotracer for quantifying brain butyrylcholinesterase activity by positron emission tomography
918
N-[1-Aryl-2-(1-imidazolo)ethyl]-guanidine derivatives as potent inhibitors of the bovine mitochondrial F1F0 ATP hydrolase
919
N-[2-(1-cyclohexenyl)ethyl]-N′-[2-(5-bromopyridyl)]-thiourea and N′-[2-(1-cyclohexenyl)ethyl]-N′-[2-(5-chloropyridyl)]- thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1
920
N-[2-(4-methoxyphenyltelluro)ethyl]phthalimide (L1): synthesis, oxidation by ruthenium(III) chloride and ligation with ruthenium(II). Crystal structures of L1, its oxidized product and of [RuCl2(p-cymene)·L1]
921
N-[2-(Indan-1-yl)-3-mercapto-propionyl] amino acids as highly potent inhibitors of the three vasopeptidases (NEP, ACE, ECE): In vitro and In vivo activities
922
N-[2-(Tri­fluoro­meth­yl)phen­yl]maleamic acid: crystal structure and Hirshfeld surface analysis
923
N-[2-Chloro-9H-purin-6-yl]-N-cyclopropylglycylamino acids and derivatives: Synthesis, evaluation as a class of novel analgesics, and 3D QSAR analysis Original Research Article
924
N-[4-(1,1′-biphenyl)methyl]-4-(4-thiomorpholinylmethyl) benzenamines as non-oxazolidinone analogues of antimycobacterial U-100480
925
N-[4-(3-methyl-3-mesityl-cyclobutyl)-thiazol-2-yl]-succinamic acid: X-ray structure, spectroscopic characterization and quantum chemical computational studies
926
N-[4-(Dimethyl Amino) Benzylidene] Benzoxide as a New Luminophor in Peroxyoxalate Chemiluminescence System for the Determination of Sucrose
927
N-[4-(Methylsulfonylamino)benzyl]thiourea analogues as vanilloid receptor antagonists: analysis of structure–activity relationships for the ‘C-Region’ Original Research Article
928
N-[Chloro(dimethylamino)methylene]-N-methylmethanaminium chloride (TMUCl Cl), the reagent of choice for the solid-phase synthesis of anilides
929
N-[hydroxy(dimethyl)silylmethyl]-N,N′-propylene urea hydrochloride: Synthesis and structure
930
N^1,N^1,N^2,N^2-tetramethyl-N^1,N^2-bis(sulfo)ethane-1,2-diaminium trifluoroacetate as an efficacious and dual-functional catalyst for the solvent-free preparation of pyrido[2,3-d:6,5-d′]dipyrimidines
931
N^N^C platinum(II) and palladium(II) cyclometallates of 6,6′-diphenyl-2,2′-bipyridine, L: Crystal and molecular structure of [Pd(L–H)Cl]
932
N_ψ-Type Quotient Modules in H^2(D^n)
933
N-{[1-(2-Phenylethyl)pyrrolidin-2-yl]methyl}cyclohexane-carboxamides as selective 5-HT1A receptor agonists
934
N-{2-(4-Methoxyphenyltelluro)ethyl}morpholine (L1) and bis{2-(N-morpholino)ethyl}telluride (L2): synthesis and complexation with palladium(II) and mercury(II). Crystal structures of trans-[PdCl2(L1)2] and trans-[PdCl2(L2)2]
935
N-{2-(4-methoxyphenyltelluro)ethyl}morpholine (L1) and its platinum(II) and ruthenium(II) complexes. Synthesis and crystal structure of L1 and trans-[PtCl2(L1)2]
936
N-{2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl}acetamide: an orally bioavailable melatonin receptor agonist
937
N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl}arylcarboxamides as novel dopamine D3 receptor antagonists
938
N′-(2-methoxy-benzylidene)-N-[4-(3-methyl-3-phenyl-cyclobutyl)-thiazol-2-yl]-chloro-acetic hydrazide: X-ray structure, spectroscopic characterization and DFT studies
939
N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists
940
N′,2-Diphenylquinoline-4-carbohydrazide based NK3 receptor antagonists II
941
N′-[(1E)-(5-Nitro­furan-2-yl)methyl­­idene]thio­phene-2-carbohydrazide: crystal structure and Hirshfeld surface analysis
942
N′-[1-(5-Bromo-2-hy­dr­oxy­phen­yl)ethyl­­idene]isonicotinohydrazide monohydrate: crystal structure and Hirshfeld surface analysis
943
N′-[2-(2-thiophene)ethyl]-N′-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of nni-resistant and multidrug-resistant human immunodeficiency virus-1
944
N′-[4-(diethylamino)benzylidine]-3-{[8-(trifluoromethyl) quinolin-4-yl]thio}propano hydrazide) as an effective inhibitor of mild steel corrosion in acid media
945
N+-implantation induced enhanced adhesion in WC1−xTi-6Al-4V
946
N− Transvectants
947
n−3 PUFA and membrane microdomains: a new frontier in bioactive lipid research
948
n−ABSORBING I−PRIME HYPERIDEALS IN MULTIPLICATIVE HYPERRINGS
949
N−Legendre and N−Slant Curves in the Unit Tangent Bundles of Minkowski Surfaces with Natural Diagonal Structures
950
N∗ and Λ∗ searches at BEijing Spectrometer (BES) Original Research Article
951
N∗ electroproduction amplitudes in a model with dynamical confinement
952
N∗, Λ∗, Σ∗ and Ξ∗ resonances from J/Ψ and Ψ′ decays Original Research Article
953
N∗—an agent-based negotiation algorithm for dynamic scheduling and rescheduling
954
N=(1,1) super-Yang–Mills on a (2+1)-dimensional transverse lattice with one exact supersymmetry
955
N=(4,2) chiral supergravity in six dimensions and solvable Lie algebras
956
N=(4,4) , 2D supergravity in SU(2)×SU(2) harmonic superspace
957
N=(4,4) 2D supersymmetric gauge theory and brane configuration
958
N=0 supersymmetry and the non-relativistic monopole
959
N=1 and N=2 supersymmetric non-abelian Born–Infeld actions from superspace
960
N=1 and N=2 super-Yang–Mills theories from wrapped branes Original Research Article
961
N=1 no-scale supergravity from IIB orientifolds
962
N=1 super Yang-Mills theories and wrapped branes
963
N=1 Superconformal Symmetry in Four-Dimensional Quantum Field Theory
964
N=1 supersymmetric boundary bootstrap Original Research Article
965
N=1 supersymmetric sigma model with boundaries, II Original Research Article
966
N=1 supersymmetric theory of higher spin gauge fields in AdS5 at the cubic level Original Research Article
967
N=1 super-Yang–Mills renormalization schemes for fractional branes
968
N=1 type IIA brane configurations, chirality and T-duality
969
N=1, D=10 tensionless superbranes
970
N=1, D=10 tensionless superbranes II
971
N=1,2 4D superconformal field theories and supergravity in AdS5
972
N=2 6-dimensional supersymmetric E6 breaking
973
N=2 and N=4 supersymmetric Born–Infeld theories from nonlinear realizations
974
N=2 boundary supersymmetry in integrable models and perturbed boundary conformal field theory Original Research Article
975
N=2 chiral supergravity in (10+2)-dimensions as consistent background for super (2+2)-brane
976
n=2 Compensation and variable gains for JET vertical stabilisation
977
N=2 conformal field theories from M2-branes at conifold singularities
978
N=2 gauge theories and systems with fractional branes Original Researc
979
N=2 gauge theories from wrapped five-branes
980
n=2 Member of the hexagonal perovskite-intergrowth manganate family An+1MnnO3n+3(Ca2O)
981
N=2 quantum string scattering
982
N=2 SCFT and M theory on AdS4×Q1,1,1
983
N=2 superconformal boundary states for free bosons and fermions Original Research Article
984
N=2 superfields and the M-fivebrane
985
N=2 supergravity models with stable de Sitter vacua
986
N=2 supersymmetric gauge theories with massive hypermultiplets and the Whitham hierarchy Original
987
N=2 supersymmetric GUT breaking on T2 orbifolds Original Research Article
988
N=2 supersymmetric kinks and real algebraic curves
989
N=2 supersymmetric quantum black holes in five dimensional heterotic string vacua
990
N=2 supersymmetric RG flows and the IIB dilaton Original
991
N=2 supersymmetry in a hybrid inflation model
992
N=3 supersymmetric Born–Infeld theory Original Research Article
993
N=4 super Yang–Mills low-energy effective action at three and four loops
994
N=4 superconformal mechanics and the potential structure of AdS spaces
995
N=8 matter coupled AdS3 supergravities
996
N=8 superconformal mechanics Original Research Article
997
N→As intramolecularly coordinated organoarsenic(III) chalcogenides: Isolation of terminal As–S and As–Se bonds
998
N1- and C6-substituted adenines: a regioselective and efficient synthesis
999
N1 and P2 components of auditory event-related potentials in children with and without reading disabilities
1000
N1 and P300 abnormalities in patients with schizophrenia, epilepsy, and epilepsy with schizophrenialike features
بازگشت